---
title: "Ocugen Inc. Stock Falls Wednesday, Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285444180.md"
description: "Shares of Ocugen Inc. (OCGN) fell 2.35% to $1.46 on Wednesday, underperforming the market as the S&P 500 rose 1.46% and the Dow Jones increased by 1.24%. This marks the second consecutive day of losses for Ocugen, which is now 46.61% below its 52-week high of $2.73 reached on March 17. Trading volume was 15.4 million, surpassing the 50-day average of 9.4 million."
datetime: "2026-05-06T21:27:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285444180.md)
  - [en](https://longbridge.com/en/news/285444180.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285444180.md)
---

# Ocugen Inc. Stock Falls Wednesday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) slipped 2.35% to $1.46 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.46% to 7,365.12 and the Dow Jones Industrial Average rising 1.24% to 49,910.59.

This was the stock's second consecutive day of losses.

Ocugen Inc. closed 46.61% below its 52-week high of $2.73, which the company reached on March 17th.

Trading volume (15.4 M) eclipsed its 50-day average volume of 9.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 6, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-06-26 1727ET

### Related Stocks

- [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)
- [MiNK Therapeutics' Q1 net loss narrows slightly](https://longbridge.com/en/news/286558132.md)